Lead Identification Through In Silico Studies: Targeting Acetylcholinesterase Enzyme Against Alzheimer's Disease.

Dhairiya AgarwalSumit KumarRamesh AmbatwarNeeru BhanwalaLokesh ChandrakarGopal L Khatik

Published in: Central nervous system agents in medicinal chemistry (2024)

A lead compound, 3v_Evo_4 molecule, was identified to inhibit AChE, and it could be further studied to develop as a drug with better efficacy than the existing available drugs for treating AD.

Keyphrases

molecular docking
cognitive decline
drug induced
cancer therapy
case control
emergency department
bioinformatics analysis
adverse drug
solid state
electronic health record